Cellebrite DI (CLBT) Fundamentals 2026 — P/E 48.9x, Revenue Analysis | SniperIQ
Cellebrite DI (CLBT) is a IL-listed Technology company in Software - Infrastructure with a market capitalization of
Cellebrite DI (CLBT) has a market capitalization of approximately
Cellebrite DI's trailing twelve-month P/E ratio is 48.9x, with a price-to-book (P/B) of 6.9x. Valuation multiples are best compared with Technology sector peers rather than read in isolation.
Cellebrite DI runs a net profit margin of 14.5%, a gross margin of 83.9%, and an operating margin of 12.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
Cellebrite DI reported revenue of $476M for fiscal year 2025, with net income of $78M and earnings per share (EPS) of 0.32. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Cellebrite DI does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Cellebrite DI carries a debt-to-equity ratio of 0.04x and a current ratio of 1.53x, with a market beta of 1.17. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Cellebrite DI (CLBT) the key facts are: market cap
Get Cellebrite DI's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.